UNSPSC 51111863: Octreotide

This classification denotes a somatostatin receptor agonist with the molecular formula C49H66N10O10S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RWM8CCW8GP, chemically known as l-cysteinamide, d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (r-(r*,r*))- but generally known as octreotide, which bears US NIH Compound Identifier 383414.

UNSPSC 51111863 Octreotide is a Commodity code tracking procurement of this synthetic somatostatin analog, a pharmaceutical used primarily to manage acromegaly, carcinoid syndrome, and variceal bleeding in state and local healthcare settings. State and local governments procure octreotide through health departments, Medicaid programs, correctional health systems, and public hospital networks as a prescribed medication covered under formularies and pharmaceutical benefit plans. The drug is typically sourced through group purchasing organizations, state pharmaceutical contracts, and direct vendor agreements that aggregate volume across multiple institutions and departments within a jurisdiction.

The source provides no recent state and local contract opportunities tagged to this code. Without posted RFP, RFQ, IFB, or ITB notices, geographic concentration and representative recent solicitation activity cannot be characterized from available procurement records.